01498.HK
PuraPharm Corporation Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.27
+3.85%Margins
Gross margin
54.2%
EBITDA margin
5.0%
EBIT margin
-8.8%
Net margin
-9.9%
FCF margin
7.7%
-53.0%
Return on equity
-9.5%
Return on assets
-11.9%
Return on invested capital
0.96x
Asset turnover
HKD 67.6M
Cash from operations
HKD 0.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026